MedPath

carboprost tromethamine

Carboprost Tromethamine Injection, USP [250 mcg/mL (1 mL)] Rx Only

Approved
Approval ID

eac3fd1c-ca4b-4aa3-9dc2-e7dbeb4c122a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 23, 2023

Manufacturers
FDA

Amneal Pharmaceuticals LLC

DUNS: 827748190

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

carboprost tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70121-1680
Application NumberANDA215337
Product Classification
M
Marketing Category
C73584
G
Generic Name
carboprost tromethamine
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateDecember 23, 2023
FDA Product Classification

INGREDIENTS (6)

CARBOPROST TROMETHAMINEActive
Quantity: 250 ug in 1 mL
Code: U4526F86FJ
Classification: ACTIM
TROMETHAMINEInactive
Quantity: 83 ug in 1 mL
Code: 023C2WHX2V
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 9.45 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

carboprost tromethamine - FDA Drug Approval Details